Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Arecor Therape Share Price
  4. Arecor Therape Share Regulatory News

Pin to quick picksArecor Therape Regulatory News (AREC)

Arecor Therape Information

Share Price Information for Arecor Therape (AREC)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (12.903%)
Market Cap: £24.92m
AREC Live PriceLast checked at - London Stock Exchange

Intraday Arecor Therape Share Chart

1234
Date   Source Headline
23rd Jul 20247:00 amRNSResult of WRAP Retail Offer
19th Jul 20246:22 pmRNSResult of Placing and Subscription
19th Jul 20241:17 pmRNSWRAP Retail Offer to raise up to £1 million
19th Jul 20241:10 pmRNSProposed Placing and Subscription
28th Jun 20242:35 pmRNSResult of AGM
10th Jun 20247:00 amRNSTrading and Funding Update
31st May 20244:05 pmRNSPosting of 2023 Annual Report and Notice of AGM
23rd May 20247:00 amRNSGrant of Options and PDMR Dealing
21st May 20247:00 amRNSArecor to host company and KOL webinar today
20th May 20247:00 amRNSPositive headline results for AT278 clinical trial
16th May 20247:00 amRNSFinal results for 2023
14th May 202410:17 amRNSNotice of Results
9th May 20247:00 amRNSArecor and Medtronic Diabetes collaboration
3rd May 20244:44 pmRNSPublication of Full Year Financial Results delayed
29th Apr 20247:00 amRNSNotice of results
23rd Apr 20247:00 amRNSBOARD CHANGE
12th Mar 20248:58 amRNSArecor and TRx Biosciences research collaboration
12th Mar 20247:00 amRNSArecor and TRx Biosciences research collaboration
29th Feb 20247:00 amRNSArecor announces launch of Ogluo® in Netherlands
1st Feb 20247:00 amRNSYear End Trading Update
23rd Jan 20244:58 pmRNSArecor announces update on INBRX-101
18th Jan 20247:00 amRNSArecor granted key European patent
8th Jan 20247:00 amRNSExpansion of specialty hospital collaboration
3rd Jan 20247:00 amRNSAppointment of SVP for Tetris Pharma Ltd
4th Dec 20237:00 amRNSAgreement with global medical products company
29th Nov 20237:00 amRNSArecor Continues Collaboration with Lilly
17th Nov 20237:00 amRNSProduct with Arestat technology launched in Europe
2nd Nov 20237:00 amRNSInhibrx milestone triggers payment to Arecor
1st Nov 20233:31 pmRNSExercise of rollover options & Total Voting Rights
2nd Oct 20237:00 amRNSProgress of Phase I clinical study of AT278
15th Sep 20237:00 amRNSArecor on Investor Meet Company Platform
14th Sep 20237:00 amRNSInterim Results for six months ended 30 June 2023
7th Sep 20237:00 amRNSArecor: positive Hikma FDA pre-IND meeting
4th Sep 20237:00 amRNSTETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
17th Aug 20237:00 amRNSCollaboration With Top 10 Global Pharma
10th Aug 20237:00 amRNSNotice of Interim Results
20th Jul 20237:00 amRNSArecor Business Update
5th Jul 20237:00 amRNSAdditional Agreement with Leading Biopharma
27th Jun 20237:00 amRNSArecor granted key patents in Europe and China
26th Jun 20237:00 amRNSArecor presents positive data for AT247 at ADA
9th Jun 20233:35 pmRNSExercise of rollover options & Total Voting Rights
9th Jun 202312:43 pmRNSResult of AGM
9th Jun 20237:00 amRNSAGM Statement
24th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSTETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
4th May 20234:00 pmRNSARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
26th Apr 20237:00 amRNSArecor Granted Key U.S Patent
21st Apr 20237:00 amRNSArecor on Investor Meet Company Platform
20th Apr 20237:00 amRNSUnaudited Preliminary Results for 2022
5th Apr 20237:00 amRNSArecor Appoints Chief Business Officer
1234

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
AAS
Aberdeen Asia
LSE
0.00%
BKY
Berkeley Eng
LSE
0.00%
JZCP
Jz Capital
LSE
0.00%
FPM
Faroe Petroleum Plc
LSE
0.00%
TPT
Topps Tiles
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
LLOY
Lloyds
LSE
0.00%
GGP
Greatland Resources
LSE
0.00%
GST
GSTechnologies
LSE
0.00%
HE1
Helium One
LSE
0.00%